Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

160
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
160
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
RNA Editing02:23

RNA Editing

9.7K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.7K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.4K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mitochondrial cardiolipin sequestration of caspofungin underlies <i>Cryptococcus neoformans</i> inherent resistance and may contribute to cardiotoxicity.

bioRxiv : the preprint server for biology·2026
Same author

Fluorescent Probes Derived from the Polyene Class of Antifungal Drugs Reveal Distinct Localization Patterns and Resistance-Associated Vacuolar Sequestration in Candida Species.

Angewandte Chemie (International ed. in English)·2025
Same author

Boosting Chemiexcitation of Phenoxy-1,2-dioxetanes through 7-Norbornyl and Homocubanyl Spirofusion.

JACS Au·2024
Same author

Chiral Fluorescent Antifungal Azole Probes Detect Resistance, Uptake Dynamics, and Subcellular Distribution in <i>Candida</i> Species.

JACS Au·2024
Same author

Poacic Acid, a Plant-Derived Stilbenoid, Augments Cell Wall Chitin Production, but Its Antifungal Activity Is Hindered by This Polysaccharide and by Fungal Essential Metals.

Biochemistry·2024
Same author

Hyper-Responsive Chemiluminescent Probe Reveals Distinct PYRase Activity in <i>Pseudomonas aeruginosa</i>.

Bioconjugate chemistry·2024

関連する実験動画

Updated: Dec 30, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.8K

化学的変化は,アミノグリコシド抗生物質によって誘発された聴覚細胞の損傷を減少させる

Sivan Louzoun Zada1, Bar Ben Baruch1, Luba Simhaev2

  • 1School of Chemistry, Raymond and Beverley Sackler Faculty of Exact Sciences , Tel Aviv University , Tel Aviv , Israel , 6997801.

Journal of the American Chemical Society
|January 22, 2020
PubMed
まとめ
この要約は機械生成です。

アミノグリコシド抗生物質の化学的改変は,リボソーム相互作用と非リボソーム効果を変化させることで,聴覚障害を軽減することができます. この研究はより安全な抗生物質治療の開発のための新しいアプローチを示唆しています.

さらに関連する動画

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

14.5K
The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

18.2K

関連する実験動画

Last Updated: Dec 30, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.8K
Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
09:06

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

14.5K
The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

18.2K

科学分野:

  • 薬理学について
  • 分子生物学
  • 耳毒性研究

背景:

  • アミノグリコシド抗生物質は,グラム陰性感染症の治療に不可欠です.
  • これらの薬は不可逆的な聴覚障害 (オート毒性) を引き起こします.
  • 耳毒性はリボソーム結合に関連しているが,他のメカニズムも関与している可能性がある.

研究 の 目的:

  • アミノグリコシドの化学的変化が耳毒性に影響する方法を調査する.
  • 改変されたアミノグリコシドがリボソーム機能と細胞に与える影響を調査する.
  • より安全なアミノグリコシド抗生物質を開発するための戦略を特定する.

主な方法:

  • リボソーム解読部位の相互作用を研究するために分子動力学シミュレーションを使用した.
  • ミトコンドリアと細胞質の間のタンパク質変換比を分析した.
  • アミノグリコシドによって誘発されたプラズマ膜浸透性を評価した.

主要な成果:

  • アプラミシンとジェネチシンの化学変化により 聴覚細胞の損傷が軽減されました
  • 改造されたアミノグリコシドは リボソームの解読部位の動態を変えました
  • アミノグリコシドは逆説的にタンパク質のレベルを上昇させ,血の浸透を誘導する.
  • 化学的修飾もこれらの非リボソーム効果を緩和した.

結論:

  • アミノグリコシドの耳毒性は,リボソームと非リボソームの両方のメカニズムを含んでいます.
  • アミノグリコシドによる毒性を減らすための有望な戦略です.
  • この研究は,より安全なアミノグリコシド抗生物質の設計のための新しいパラダイムを提案しています.